METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA

Clinical trials for METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a Dual-Action antibody boost chemo against bile duct cancer?

Disease control Not yet recruiting

This trial is testing whether adding ivonescimab to standard chemotherapy (gemcitabine and cisplatin) works better than the usual chemo-immunotherapy combination for people with advanced biliary tract cancer. Ivonescimab is a special antibody that targets two proteins: one that h…

Matched conditions: METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA

Phase: PHASE2, PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Aug 16, 2026 00:00 UTC

METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA

Get alerted when new METASTATIC EXTRAHEPATIC CHOLANGIOCARCINOMA trials appear

Can a Dual-Action antibody boost chemo against bile duct cancer?